Cargando…
New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection—Systematic Review
As the population recovers from the coronavirus disease 2019 (COVID-19) pandemic, a subset of individuals is emerging as post-coronavirus disease (post-COVID) patients who experience multifactorial long-term symptoms several weeks after the initial recovery from severe acute respiratory syndrome cor...
Autores principales: | Wrona, Marysia, Skrypnik, Damian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602450/ https://www.ncbi.nlm.nih.gov/pubmed/36293857 http://dx.doi.org/10.3390/ijerph192013280 |
Ejemplares similares
-
A Neutral Risk on the Development of New-Onset Diabetes Mellitus (NODM) in Taiwanese Patients with Dyslipidaemia Treated with Fibrates
por: Lee, Chien-Ying, et al.
Publicado: (2012) -
Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021) -
Angina due to hypertension and dyslipidaemia
por: Fox, Kim
Publicado: (2019) -
High prevalence of dyslipidaemia among persons with diabetes mellitus and hypertension at a tertiary hospital in Blantyre, Malawi
por: Katundu, Kondwani G. H., et al.
Publicado: (2022) -
Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica
por: Gordon, Lorenzo, et al.
Publicado: (2010)